Stock LAURUSLABS LAURUS LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Laurus Labs Limited Bombay S.E.

Equities

LAURUSLABS

INE947Q01028

Market Closed - Bombay S.E.
Other stock markets
 06:00:54 2024-06-28 am EDT 		5-day change 1st Jan Change
424.2 INR +0.12% Intraday chart for Laurus Labs Limited -1.94% -1.37%
Jun. 26 Willow Biosciences Provides Corporate Update and Signs New Partnered Program MT
Jun. 26 Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Willow Biosciences Provides Corporate Update and Signs New Partnered Program
MT
Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients
MT
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
MT
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs
CI
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
RE
Laurus Labs' Consolidated Profit Falls in Fiscal Q4
MT
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024
CI
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024
MT
Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company
MT
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%
MT
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd
CI
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio
MT
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.
CI
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023
CI
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Laurus Labs Limited agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.
CI
India's Divi's Labs Q1 profit slumps on drug pricing pressures
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAURUSLABS Stock
  4. LAURUSLABS Stock
  5. News Laurus Labs Limited
  6. Highlights